Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Algeria

Algeria: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 92.0% in 2025. ▼ Falling

Latest (2025)
92.0%
Change on year
up 2.2%
World rank
56th
of 194 countries
All-time high
99.0%
in 2014
All-time low
71.0%
in 2022
Years of data
26
2000–2025

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria, 2000–2025

0204060801002000201220252000: 782001: 732002: 932003: 962004: 942005: 942006: 982007: 952008: 962009: 982010: 952011: 962012: 952013: 932014: 992015: 992016: 962017: 922018: 772019: 762020: 742021: 732022: 712023: 932024: 902025: 92

Source: World Health Organization, Global Health Observatory.

Analysis

In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria stood at 92.0%.

Compared with earlier readings it is up 2.2% on the previous year and down 7.1% over ten years.

Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria peaked at 99.0% in 2014 and was at its lowest, 71.0%, in 2022.

Algeria ranks 56th of 194 countries on this measure, in the middle of the range.

The long-run direction has been consistently falling across the 26 years of available data.

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria, year by year

Annual values for Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) in Algeria, 2000 to 2025.
Year Value Change
2000 78.0% —
2001 73.0% -6.4%
2002 93.0% +27.4%
2003 96.0% +3.2%
2004 94.0% -2.1%
2005 94.0% +0.0%
2006 98.0% +4.3%
2007 95.0% -3.1%
2008 96.0% +1.1%
2009 98.0% +2.1%
2010 95.0% -3.1%
2011 96.0% +1.1%
2012 95.0% -1.0%
2013 93.0% -2.1%
2014 99.0% +6.5%
2015 99.0% +0.0%
2016 96.0% -3.0%
2017 92.0% -4.2%
2018 77.0% -16.3%
2019 76.0% -1.3%
2020 74.0% -2.6%
2021 73.0% -1.4%
2022 71.0% -2.7%
2023 93.0% +31.0%
2024 90.0% -3.2%
2025 92.0% +2.2%

Algeria compared with similar countries

  • Algeria's 92.0% is above the median for upper middle income countries, which is 85.0%, 1.1× the median. (57 countries reporting)
  • Algeria's 92.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 92.0%, 1.0× the median. (23 countries reporting)

Biggest year-on-year movements

Years where Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2023 +31.0% 71.0% 93.0%
2002 +27.4% 73.0% 93.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 91.5% 73.0% 98.0% 10
2010s 91.8% 76.0% 99.0% 10
2020s 82.2% 71.0% 93.0% 6

Countries ranked near Algeria

  1. 56 Finland 92.0% compare
  2. 56 Germany 92.0% compare
  3. 56 Spain 92.0% compare
  4. 56 Israel 92.0% compare
  5. 56 Nepal 92.0% compare
  6. 56 United Arab Emirates 92.0% compare
  7. 56 Ghana 92.0% compare
  8. 56 Costa Rica 92.0% compare
  9. 56 Switzerland 92.0% compare

See the full ranking of 207 places →

More health data for Algeria

All data for Algeria →

Frequently asked questions

What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria?
Measles-containing-vaccine second-dose (mcv2) immunization coverage in Algeria was 92.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Algeria?
The highest recorded value was 99.0% in 2014.
What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Algeria?
The lowest recorded value was 71.0% in 2022.
How does Algeria rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
Algeria ranks 56th out of 194 countries with data for 2025.
Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Algeria?
Over the last ten years it is down 7.1%. The long-run trend across the full record is falling.
Where does this Algeria data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 October 2026, from https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/algeria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/algeria/">Measles-containing-vaccine second-dose (MCV2) immunization coverage in Algeria</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed